Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

One-shot addiction treatment shows promise

08.01.2004


Long-lasting depot medication appears safe and effective for treatment of narcotic addiction

A study in the January issue of the journal Drug and Alcohol Dependence reports that a long-lasting depot medication appears safe and effective for treatment of narcotic addiction. In the study a single injection prevented withdrawal discomfort for 6 weeks in heroin-dependent patients, reduced the effects of injected opiates, and provided a comfortable detoxification as it gradually wore off.

The study medication was an experimental injectable sustained-release depot formulation of the medication buprenorphine. The injection is a suspension of biodegradable microcapsules each containing small amounts of the buprenorphine medication. As the microcapsules gradually disintegrate they provide a long-duration sustained release of buprenorphine. A tablet form of buprenorphine that is taken by holding it under the tongue is already used in the U.S. and around the world as an analgesic and as a treatment for opioid dependence; the tablet normally needs to be taken every day. The recent study was the first to test this new long-lasting depot formulation in humans. The study examined the safety and pharmacokinetics of the depot medication, and tested its effectiveness for reducing the opioid withdrawal syndrome and for reducing the effects of opioid challenge injections.



Participants were five volunteer physically dependent heroin abusers. In a residential laboratory setting the heroin abusers each had their narcotics abruptly stopped and was instead given a depot injection of 58 mg of buprenorphine. For the next 6 weeks the patients were assessed repeatedly for signs and symptoms of the opioid withdrawal syndrome. In addition, the volunteers received weekly challenge injections of the opioid hydromorphone (Dilaudid) to test whether their sensitivity to opioids was reduced by the depot buprenorphine treatment.

The results were promising both for prevention of the opioid withdrawal syndrome and for blockade of the opioid high from the hydromorphone challenge injections. No significant withdrawal syndrome occurred and no patient required additional medications. In addition, the effect of the opioid challenge injections appeared considerably reduced. No significant side effects were reported.

The ability of a single medication dose to have beneficial effects over 4 to 6 weeks is a significant finding for the treatment of opioid dependence. Further research will need to determine how this new product can best be used.

The depot medication holds promise both as a one shot detoxification treatment and as an alternative maintenance treatment. With the recent advent in the U.S. of office-based addiction treatment with sublingual buprenorphine, this longer-acting formulation could increase patient adherence to treatment, ease the visit burden on both patients and providers, and make treatment more accessible.

The study was conducted by researchers at the Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, of the Johns Hopkins University School of Medicine in Baltimore, Maryland, under research grant support from the National Institute on Drug Abuse. The depot medication was developed and produced by Biotek, Inc. of Woburn, Massachusetts.

The study appeared in the journal Drug and Alcohol Dependence. Authors were Bai-Fang X. Sobel, Stacey C. Sigmon, Rolley E. Johnson, Ira A. Liebson and George Bigelow from the Johns Hopkins University School of Medicine, and Elie S. Nuwayser and James H. Kerrigan from Biotek, Inc.

For more information, please contact:

George E. Bigelow
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224-6823, USA
Email: bigelow@jhmi.edu

George E. Bigelow | EurekAlert!
Further information:
http://www.elsevier.com/locate/drugalcdep
http://dx.doi.org/10.1016/j.drugalcdep.2003.08.006

More articles from Social Sciences:

nachricht Amazingly flexible: Learning to read in your thirties profoundly transforms the brain
26.05.2017 | Max-Planck-Institut für Kognitions- und Neurowissenschaften

nachricht Fixating on faces
26.01.2017 | California Institute of Technology

All articles from Social Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: 3-D scanning with water

3-D shape acquisition using water displacement as the shape sensor for the reconstruction of complex objects

A global team of computer scientists and engineers have developed an innovative technique that more completely reconstructs challenging 3D objects. An ancient...

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

Im Focus: On the way to a biological alternative

A bacterial enzyme enables reactions that open up alternatives to key industrial chemical processes

The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....

Im Focus: The 1 trillion tonne iceberg

Larsen C Ice Shelf rift finally breaks through

A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

 
Latest News

Ultrathin device harvests electricity from human motion

24.07.2017 | Power and Electrical Engineering

Scientists announce the quest for high-index materials

24.07.2017 | Materials Sciences

ADIR Project: Lasers Recover Valuable Materials

24.07.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>